The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12-08

AUTHORS

Małgorzata Mikulska, Thierry Calandra, Maurizio Sanguinetti, Daniel Poulain, Claudio Viscoli, the Third European Conference on Infections in Leukemia Group

ABSTRACT

IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia™, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing. More... »

PAGES

r222

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/cc9365

DOI

http://dx.doi.org/10.1186/cc9365

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035798140

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21143834


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Fungal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Fungal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candida", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Candidiasis, Invasive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Congresses as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Europe", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mannans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.410345.7", 
          "name": [
            "Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mikulska", 
        "givenName": "Ma\u0142gorzata", 
        "id": "sg:person.01272344176.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272344176.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.9851.5", 
          "name": [
            "Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Calandra", 
        "givenName": "Thierry", 
        "id": "sg:person.01103701061.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universit\u00e0 Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.8142.f", 
          "name": [
            "Universit\u00e0 Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sanguinetti", 
        "givenName": "Maurizio", 
        "id": "sg:person.0775516471.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775516471.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Unit\u00e9 Inserm U799, Facult\u00e9 de M\u00e9decine, P\u00f4le Recherche, Place Verdun, F-59045, Lille, cedex, France", 
          "id": "http://www.grid.ac/institutes/grid.7429.8", 
          "name": [
            "Unit\u00e9 Inserm U799, Facult\u00e9 de M\u00e9decine, P\u00f4le Recherche, Place Verdun, F-59045, Lille, cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Poulain", 
        "givenName": "Daniel", 
        "id": "sg:person.01035744051.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035744051.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viscoli", 
        "givenName": "Claudio", 
        "id": "sg:person.01241060757.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241060757.05"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "the Third European Conference on Infections in Leukemia Group", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s100960100629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011904460", 
          "https://doi.org/10.1007/s100960100629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-007-0373-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017843109", 
          "https://doi.org/10.1007/s10096-007-0373-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2334-7-103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015191232", 
          "https://doi.org/10.1186/1471-2334-7-103"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12-08", 
    "datePublishedReg": "2010-12-08", 
    "description": "IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia\u2122, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/cc9365", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117766", 
        "issn": [
          "1364-8535", 
          "1466-609X"
        ], 
        "name": "Critical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "keywords": [
      "anti-mannan antibodies", 
      "invasive candidiasis", 
      "diagnostic odds ratio", 
      "mannan antigen", 
      "available sandwich enzyme-linked immunosorbent assay", 
      "Cancer/Mycoses Study Group criteria", 
      "Mycoses Study Group criteria", 
      "diagnosis of IC", 
      "Study Group criteria", 
      "intensive care unit", 
      "Third European Conference", 
      "positive test results", 
      "enzyme-linked immunosorbent assay", 
      "sandwich enzyme-linked immunosorbent assay", 
      "spleen lesions", 
      "clinical presentation", 
      "care unit", 
      "patient population", 
      "Group criteria", 
      "odds ratio", 
      "surgery cases", 
      "cancer cases", 
      "radiological detection", 
      "different Candida species", 
      "patients", 
      "serological tests", 
      "European Organization", 
      "culture results", 
      "MethodsThe literature", 
      "immunosorbent assay", 
      "Candida species", 
      "diagnosis", 
      "significant heterogeneity", 
      "lack sensitivity", 
      "C. glabrata", 
      "candidiasis", 
      "leukemia", 
      "infection", 
      "antigen", 
      "C. tropicalis", 
      "antibodies", 
      "days", 
      "C. albicans", 
      "specificity", 
      "candidemia", 
      "ResultsOverall", 
      "target conditions", 
      "lesions", 
      "study", 
      "liver", 
      "testing", 
      "longer incubation times", 
      "serum", 
      "sensitivity", 
      "median", 
      "treatment", 
      "cases", 
      "presentation", 
      "glabrata", 
      "test", 
      "assays", 
      "incubation time", 
      "review", 
      "European Conference", 
      "population", 
      "albicans", 
      "tropicalis", 
      "recommendations", 
      "criteria", 
      "control", 
      "test results", 
      "heterogeneity", 
      "results", 
      "time advantage", 
      "use", 
      "conference", 
      "literature", 
      "detection", 
      "units", 
      "ratio", 
      "time", 
      "research", 
      "conditions", 
      "method", 
      "organization", 
      "behalf", 
      "advantages", 
      "design", 
      "species", 
      "performance", 
      "Mn"
    ], 
    "name": "The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia", 
    "pagination": "r222", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035798140"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/cc9365"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21143834"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/cc9365", 
      "https://app.dimensions.ai/details/publication/pub.1035798140"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_509.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/cc9365"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/cc9365'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/cc9365'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      21 PREDICATES      131 URIs      120 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/cc9365 schema:about N236b0c6c1b2f4548b5d7b88d6c363ffb
2 N29cfd24822664f3eb351ad4d42d193e5
3 N408ea64b5ff24992bb84b671a45e7cdd
4 N4400a33cdd714b92b433c5c49d9069b1
5 N473045f8b3254c4286f69e59b4ff3808
6 N4c4bee7f5c8c4a9d9b113f57b16404c0
7 N53f81716f02646219430193ecfb17b0f
8 N5ef5e0ebdfd34a43b6b35cab6387d256
9 N6f8ea62f93fe457fa3be6096995cbcd5
10 Na71dc9db31984ef391e5b1dccb216d58
11 Ne42bd37744c44f9cbe056e22a6139da7
12 Nf1a7ef0bfcf34050ac078893609b24e4
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author N3782cc8cece54a6184ca06f7c026c290
16 schema:citation sg:pub.10.1007/s10096-007-0373-6
17 sg:pub.10.1007/s100960100629
18 sg:pub.10.1186/1471-2334-7-103
19 schema:datePublished 2010-12-08
20 schema:datePublishedReg 2010-12-08
21 schema:description IntroductionTimely diagnosis of invasive candidiasis (IC) remains difficult as the clinical presentation is not specific and blood cultures lack sensitivity and need a long incubation time. Thus, non-culture-based methods for diagnosing IC have been developed. Mannan antigen (Mn) and anti-mannan antibodies (A-Mn) are present in patients with IC. On behalf of the Third European Conference on Infections in Leukemia, the performance of these tests was analysed and reviewed.MethodsThe literature was searched for studies using the commercially available sandwich enzyme-linked immunosorbent assays (Platelia™, Bio-Rad Laboratories, Marnes-la-Coquette, France) for detecting Mn and A-Mn in serum. The target condition of this review was IC defined according to 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. Sensitivity, specificity and diagnostic odds ratios (DOR) were calculated for Mn, A-Mn and combined Mn/A-Mn testing.ResultsOverall, 14 studies that comprised 453 patients and 767 controls were reviewed. The patient populations included in the studies were mainly haematological and cancer cases in seven studies and mainly intensive care unit and surgery cases in the other seven studies. All studies but one were retrospective in design. Mn sensitivity was 58% (95% confidence interval [CI], 53-62); specificity, 93% (95% CI, 91-94) and DOR, 18 (95% CI 12-28). A-Mn sensitivity was 59% (95% CI, 54-65); specificity, 83% (95% CI, 79-97) and DOR, 12 (95% CI 7-21). Combined Mn/A-Mn sensitivity was 83% (95% CI, 79-87); specificity, 86% (95% CI, 82-90) and DOR, 58 (95% CI 27-122). Significant heterogeneity of the studies was detected. The sensitivity of both Mn and A-Mn varied for different Candida species, and it was the highest for C. albicans, followed by C. glabrata and C. tropicalis. In 73% of 45 patients with candidemia, at least one of the serological tests was positive before the culture results, with mean time advantage being 6 days for Mn and 7 days for A-Mn. In 21 patients with hepatosplenic IC, 18 (86%) had Mn or A-Mn positive test results at a median of 16 days before radiological detection of liver or spleen lesions.ConclusionsMn and A-Mn are useful for diagnosis of IC. The performance of combined Mn/A-Mn testing is superior to either Mn or A-Mn testing.
22 schema:genre article
23 schema:isAccessibleForFree true
24 schema:isPartOf N5aa289a9d110458e9331f04350497326
25 Nc5c1462b52304e7d85025649f2481ee0
26 sg:journal.1117766
27 schema:keywords C. albicans
28 C. glabrata
29 C. tropicalis
30 Cancer/Mycoses Study Group criteria
31 Candida species
32 European Conference
33 European Organization
34 Group criteria
35 MethodsThe literature
36 Mn
37 Mycoses Study Group criteria
38 ResultsOverall
39 Study Group criteria
40 Third European Conference
41 advantages
42 albicans
43 anti-mannan antibodies
44 antibodies
45 antigen
46 assays
47 available sandwich enzyme-linked immunosorbent assay
48 behalf
49 cancer cases
50 candidemia
51 candidiasis
52 care unit
53 cases
54 clinical presentation
55 conditions
56 conference
57 control
58 criteria
59 culture results
60 days
61 design
62 detection
63 diagnosis
64 diagnosis of IC
65 diagnostic odds ratio
66 different Candida species
67 enzyme-linked immunosorbent assay
68 glabrata
69 heterogeneity
70 immunosorbent assay
71 incubation time
72 infection
73 intensive care unit
74 invasive candidiasis
75 lack sensitivity
76 lesions
77 leukemia
78 literature
79 liver
80 longer incubation times
81 mannan antigen
82 median
83 method
84 odds ratio
85 organization
86 patient population
87 patients
88 performance
89 population
90 positive test results
91 presentation
92 radiological detection
93 ratio
94 recommendations
95 research
96 results
97 review
98 sandwich enzyme-linked immunosorbent assay
99 sensitivity
100 serological tests
101 serum
102 significant heterogeneity
103 species
104 specificity
105 spleen lesions
106 study
107 surgery cases
108 target conditions
109 test
110 test results
111 testing
112 time
113 time advantage
114 treatment
115 tropicalis
116 units
117 use
118 schema:name The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
119 schema:pagination r222
120 schema:productId N71685944bf104a449316fa0947713efd
121 Nab09cddd807a42648c035174913c0ddf
122 Nfbc710f0f4084f49bda86e2fe94204c4
123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035798140
124 https://doi.org/10.1186/cc9365
125 schema:sdDatePublished 2022-09-02T15:54
126 schema:sdLicense https://scigraph.springernature.com/explorer/license/
127 schema:sdPublisher N2007b50faa4e4413bc9f4b30bd31e4f8
128 schema:url https://doi.org/10.1186/cc9365
129 sgo:license sg:explorer/license/
130 sgo:sdDataset articles
131 rdf:type schema:ScholarlyArticle
132 N2007b50faa4e4413bc9f4b30bd31e4f8 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N236b0c6c1b2f4548b5d7b88d6c363ffb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Humans
136 rdf:type schema:DefinedTerm
137 N256a6d7c8be84fb2b7d7ca2cc6a82489 rdf:first sg:person.01035744051.24
138 rdf:rest N72fe2d1d9ff244f99e4606b52a6692db
139 N29cfd24822664f3eb351ad4d42d193e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Candida
141 rdf:type schema:DefinedTerm
142 N3782cc8cece54a6184ca06f7c026c290 rdf:first sg:person.01272344176.57
143 rdf:rest N3c942216ee2e4176820e2c275e5ff65e
144 N37b5b6ff9a624bc583a5ed2ddf8614ef schema:familyName the Third European Conference on Infections in Leukemia Group
145 rdf:type schema:Person
146 N3c942216ee2e4176820e2c275e5ff65e rdf:first sg:person.01103701061.44
147 rdf:rest N8274b0e0c6b64e85a028124e5e5341c3
148 N3dfaa303c288440e95259581711af75a rdf:first N37b5b6ff9a624bc583a5ed2ddf8614ef
149 rdf:rest rdf:nil
150 N408ea64b5ff24992bb84b671a45e7cdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Mannans
152 rdf:type schema:DefinedTerm
153 N4400a33cdd714b92b433c5c49d9069b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Congresses as Topic
155 rdf:type schema:DefinedTerm
156 N473045f8b3254c4286f69e59b4ff3808 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Randomized Controlled Trials as Topic
158 rdf:type schema:DefinedTerm
159 N4c4bee7f5c8c4a9d9b113f57b16404c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Candidiasis, Invasive
161 rdf:type schema:DefinedTerm
162 N53f81716f02646219430193ecfb17b0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Animals
164 rdf:type schema:DefinedTerm
165 N5aa289a9d110458e9331f04350497326 schema:volumeNumber 14
166 rdf:type schema:PublicationVolume
167 N5ef5e0ebdfd34a43b6b35cab6387d256 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Leukemia
169 rdf:type schema:DefinedTerm
170 N6f8ea62f93fe457fa3be6096995cbcd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Practice Guidelines as Topic
172 rdf:type schema:DefinedTerm
173 N71685944bf104a449316fa0947713efd schema:name dimensions_id
174 schema:value pub.1035798140
175 rdf:type schema:PropertyValue
176 N72fe2d1d9ff244f99e4606b52a6692db rdf:first sg:person.01241060757.05
177 rdf:rest N3dfaa303c288440e95259581711af75a
178 N8274b0e0c6b64e85a028124e5e5341c3 rdf:first sg:person.0775516471.70
179 rdf:rest N256a6d7c8be84fb2b7d7ca2cc6a82489
180 Na71dc9db31984ef391e5b1dccb216d58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Europe
182 rdf:type schema:DefinedTerm
183 Nab09cddd807a42648c035174913c0ddf schema:name pubmed_id
184 schema:value 21143834
185 rdf:type schema:PropertyValue
186 Nc5c1462b52304e7d85025649f2481ee0 schema:issueNumber 6
187 rdf:type schema:PublicationIssue
188 Ne42bd37744c44f9cbe056e22a6139da7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Antibodies, Fungal
190 rdf:type schema:DefinedTerm
191 Nf1a7ef0bfcf34050ac078893609b24e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Antigens, Fungal
193 rdf:type schema:DefinedTerm
194 Nfbc710f0f4084f49bda86e2fe94204c4 schema:name doi
195 schema:value 10.1186/cc9365
196 rdf:type schema:PropertyValue
197 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
198 schema:name Medical and Health Sciences
199 rdf:type schema:DefinedTerm
200 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
201 schema:name Oncology and Carcinogenesis
202 rdf:type schema:DefinedTerm
203 sg:journal.1117766 schema:issn 1364-8535
204 1466-609X
205 schema:name Critical Care
206 schema:publisher Springer Nature
207 rdf:type schema:Periodical
208 sg:person.01035744051.24 schema:affiliation grid-institutes:grid.7429.8
209 schema:familyName Poulain
210 schema:givenName Daniel
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035744051.24
212 rdf:type schema:Person
213 sg:person.01103701061.44 schema:affiliation grid-institutes:grid.9851.5
214 schema:familyName Calandra
215 schema:givenName Thierry
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44
217 rdf:type schema:Person
218 sg:person.01241060757.05 schema:affiliation grid-institutes:None
219 schema:familyName Viscoli
220 schema:givenName Claudio
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241060757.05
222 rdf:type schema:Person
223 sg:person.01272344176.57 schema:affiliation grid-institutes:grid.410345.7
224 schema:familyName Mikulska
225 schema:givenName Małgorzata
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272344176.57
227 rdf:type schema:Person
228 sg:person.0775516471.70 schema:affiliation grid-institutes:grid.8142.f
229 schema:familyName Sanguinetti
230 schema:givenName Maurizio
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775516471.70
232 rdf:type schema:Person
233 sg:pub.10.1007/s10096-007-0373-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017843109
234 https://doi.org/10.1007/s10096-007-0373-6
235 rdf:type schema:CreativeWork
236 sg:pub.10.1007/s100960100629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011904460
237 https://doi.org/10.1007/s100960100629
238 rdf:type schema:CreativeWork
239 sg:pub.10.1186/1471-2334-7-103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015191232
240 https://doi.org/10.1186/1471-2334-7-103
241 rdf:type schema:CreativeWork
242 grid-institutes:None schema:alternateName University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
243 schema:name University of Genoa, Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
244 rdf:type schema:Organization
245 grid-institutes:grid.410345.7 schema:alternateName Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
246 schema:name Division of Infectious Diseases, San Martino University Hospital, L.go R. Benzi, 10, Genoa, Italy
247 rdf:type schema:Organization
248 grid-institutes:grid.7429.8 schema:alternateName Unité Inserm U799, Faculté de Médecine, Pôle Recherche, Place Verdun, F-59045, Lille, cedex, France
249 schema:name Unité Inserm U799, Faculté de Médecine, Pôle Recherche, Place Verdun, F-59045, Lille, cedex, France
250 rdf:type schema:Organization
251 grid-institutes:grid.8142.f schema:alternateName Università Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy
252 schema:name Università Cattolica del S. Cuore, Institute Of Microbiology, Largo F. Vito 1, 00168, Rome, Italy
253 rdf:type schema:Organization
254 grid-institutes:grid.9851.5 schema:alternateName Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland
255 schema:name Infectious Diseases Service, Department of Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, rue du Bugnon 46, CH-1011, Lausanne, Switzerland
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...